C82.88
Other types of follicular lymphoma, lymph nodes of multiple sites
Clinical Classification Guidelines
Medical Intelligence & Overview
Follicular lymphoma is a type of blood cancer that originates in the lymphatic system, specifically within the lymph nodes. It is classified as a slow-growing non-Hodgkin lymphoma, which means it can develop gradually over time. The subtype identified by ICD-10 code C82.88 involves follicular lymphoma affecting lymph nodes in multiple regions of the body. Understanding the nature of this condition can help patients recognize its signs and appreciate the importance of medical evaluation and management.
Causes & Symptoms
Clinical Causes: Genetic mutations within lymphocytes that cause abnormal growth Certain inherited genetic predispositions Environmental exposures such as chemicals or radiation (though specific causes are not well established) Immune system factors that may influence disease development
Key Symptoms: Swelling or painless lumps in the lymph nodes, often in the neck, armpits, or groin Persistent fatigue or tiredness Unexplained weight loss Fever unrelated to infections Night sweats Itching or skin changes in some cases Frequent infections if immune function is compromised
Diagnostic & Treatment
Diagnosis Path: Diagnosis generally involves a combination of clinical examination, imaging studies, and laboratory tests. The steps include: - Physical examination to assess enlarged lymph nodes - Imaging tests such as CT scans or PET scans to determine the extent of lymph node involvement - Biopsy of the affected lymph node to examine tissue under a microscope and confirm the presence of follicular lymphoma - Blood tests to evaluate overall health and detect abnormalities in blood cell counts - Bone marrow biopsy in certain cases to determine if the marrow is affected
Treatment Protocols: Treatment options depend on various factors including disease stage, symptoms, and overall health. Common approaches include: - Observation (watchful waiting) in some early and asymptomatic cases - Chemotherapy to target cancerous lymphocytes - Immunotherapy, such as monoclonal antibodies, to enhance the immune response against lymphoma - Targeted therapies that focus on specific molecular features of the cancer cells - Radiation therapy for localized disease - Stem cell transplantation in selected cases Multidisciplinary management is essential for tailored treatment planning and supportive care.
Clinical Advice & FAQs
Billing Guidance
Is C82.88 a billable ICD-10 code?
Yes, C82.88 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C82.88?
Clinical documentation must specify the nature of Other types of follicular lymphoma, lymph nodes of multiple sites and any associated comorbidities for accurate reporting.
Cite this Clinical Reference